COVID Clinical Trials
Click here to download a printable copy of this information.
COVID
Primary Site |
Sponsor/Study ID
NCT# |
Protocol Description | Eligibility |
COVID Symptoms |
Regeneron
R10933-10987-COV-2066 NCT04426695 |
A Master Protocol Assessing the Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-COV-2 Monoclonal Antibodies for the Treatment of Hospitalized Patients with COVID-19 |
|
COVID Respiratory Symptoms |
Duke University
NCT04399889 |
Pilot Study of Safety and Efficacy of Cord Tissue Derived Mesenchymal Stromal Cells (hCT-MSC) in COVID-19 Related Acute Respiratory Distress Syndrome (ARDS) |
|
COVID Respiratory Symptoms |
The Ohio State University
PreVent NCT04466683 |
Phase II Protocol of Low-Dose Whole Thorax Megavoltage Radiotherapy for Patients with SARS-CoV-2 Pneumonia |
|